Compare Etsy Inc (ETSY) vs Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Maravai LifeSciences Holdings Inc. Class A Common Stock — how do they compare? Etsy Inc trades at $82.89 (market cap $7.28B), while Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M). The key difference: Etsy Inc is far larger — about 7.5× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Etsy Inc is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days on average.
| ETSY | MRVI | |
|---|---|---|
Market Cap | $7.28B | $972.90M |
Volume | 2,112,607 | 4,325,710 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $9.00 |
52-Week Low | $44.05 | $2.83 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $9.23B | $1.08B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $79.28, up 3.05% today, with a bullish technical signal and strong institutional interest. Recent earnings beats and a 71.4% gross margin highlight operational strength, though net income margin compressed to 5.65% in 2025. The stock is near its consensus price target of $85.94, with positive sentiment driven by AI initiatives and partnership renewals.
Outlook is cautiously optimistic given analyst support and growth initiatives, but risks include high debt-to-asset ratio (105.48% in 2025) and competitive e-commerce pressures. Upside hinges on AI-driven personalization boosting revenue, while margin pressure and macroeconomic headwinds pose challenges.
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →
